Finally a Go-To resource for designing strategies and implementing Kaizen in Pharmaceuticals, Medical devices and Biotech industries...
Dr.Shruti Bhat, Star formulator and Ace leader within pharmaceutical R&D. Shruti is a specialist with hiTech formulations, pharmaceutical patents and quality-by-design. Shruti brings to you some highlights from current patent news, views and data.
In recent quarters, expiring patents in the product lines of the major pharmaceutical companies has become a hot topic. Over the next five years drug companies are expected to lose several patents. In order to compensate for expiring drug patents drug companies have been focusing on mergers and acquisitions in order to shore up their patent lines. Biotech firms in particular have been a beneficiary of this drive to sign agreements with smaller companies.
Disclaimer- The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
New Paperback Released!
New Online Course Released!